Document is current

Any future updates will be listed below

March-in rights under the Bayh–Dole Act undermine the US drug development sector without lowering drug costs

Crossref DOI link: https://doi.org/10.1038/s41587-025-02934-z

Published Online: 2025-12-02

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark